US 12,110,300 B2
Liquid pharmaceutical composition of gold
Anvarhusein A. Isab, Dhahran (SA); and Adam Ahmed Abdullah Sulaiman, Dhahran (SA)
Assigned to KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS, Dhahran (SA)
Filed by KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS, Dhahran (SA)
Filed on Mar. 15, 2024, as Appl. No. 18/606,361.
Application 18/606,361 is a continuation of application No. 17/825,009, filed on May 26, 2022, granted, now 11,958,867.
Application 17/825,009 is a continuation of application No. 16/554,224, filed on Aug. 28, 2019, granted, now 11,384,100, issued on Jul. 12, 2022.
Prior Publication US 2024/0279243 A1, Aug. 22, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61P 35/00 (2006.01); C07F 1/00 (2006.01)
CPC C07F 1/005 (2013.01) [A61P 35/00 (2018.01)] 5 Claims
 
1. A liquid pharmaceutical composition, comprising:
a gold (III) complex of formula (I),

OG Complex Work Unit Chemistry
a saline carrier liquid, and
a pharmaceutically acceptable excipient selected from the group consisting of lactose, glucose, and sucrose;
wherein:
R1 and R2 are each independently a hydrogen or an optionally substituted arylalkyl;
R3 and R4 are each independently a hydrogen, an optionally substituted alkoxy, or a hydroxyl; and
X is Cl or Br.